---
title: Omniabio vs Porton Advanced
slug_a: omniabio
slug_b: porton-advanced
site: cdmo
review_signal_gate: closed
canonical_path: /compare/omniabio/porton-advanced
generated_by: BioBM Editorial AI
---

# Omniabio vs Porton Advanced

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Omniabio (omniabio) is listed for cdmo. OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (8).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Porton Advanced (porton-advanced) is listed for cdmo. End-to-end ATMP CDMO provider offering cell engineering, lentiviral vectors, mRNA/LNP, plasmid development, and GMP manufacturing from preclinical through commercialization with 24 IND approvals across NMPA, FDA, and MedSafe.

Services: 14. Modalities: 4. Indications: 0. Locations: 18. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in locations (18).

Review summary: Review summary withheld until site-level review gate opens.